From Passion To Product to Patient ®

BCA-225

Anti-BCA-225 antibody recognizes a human breast carcinoma associated glycoprotein BCA-225 (220-225kD). This protein differs in size and distribution from other breast carcinoma antigens. Unlike other antibodies against breast carcinoma antigens, this antibody does not react with benign or malignant colonic, stomach, prostate, liver, pancreas, thyroid, or parotid tissues. Adenocarcinomas of the lung, ovary and endometrium also stain with this antibody.

 Mouse Monoclonal, Clone: Cu-18
    0.1 ml concentrated225M-14
    0.5 ml concentrated225M-15
    1 ml concentrated225M-16
    1 ml prediluted225M-17
    7 ml prediluted225M-18
    Ventana®* dispenser760-2607
    5 Positive Control Slides 225S
Regulatory Status

USIVD
CanadaIVD
European UnionIVD
AustraliaIVD
JapanRUO



Site Map | Privacy Policy/Terms of Use
©2010 Cell Marque Corporation All Rights Reserved